Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 32.78
-0.94 (-2.79%)
Aug 3, 2026, 1:42 PM CET
Nanobiotix Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.96 | -68.13 | -39.7 | -57.04 | -47 |
Depreciation & Amortization | 1.49 | 1.62 | 1.51 | 1.5 | 1.56 |
Other Amortization | 0 | 0 | - | - | - |
Loss (Gain) From Sale of Assets | 0.15 | -0 | -0.02 | 0 | - |
Stock-Based Compensation | 3.54 | 4.3 | 3.22 | 3.17 | 3.2 |
Other Operating Activities | -11.25 | 28.38 | 12.59 | 12.96 | 0.83 |
Change in Accounts Receivable | 0.84 | -2.07 | -0.81 | -0.1 | 0.06 |
Change in Accounts Payable | -5.41 | 1.96 | 8.68 | 2.91 | -0.28 |
Change in Unearned Revenue | -0.02 | 12.19 | 1.61 | - | 16.52 |
Change in Other Net Operating Assets | 1.19 | 2.2 | 0.44 | -0.51 | -4.76 |
Operating Cash Flow | -33.42 | -19.55 | -12.48 | -37.1 | -29.87 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.54 | -0.85 | -0.33 | -0.09 | -0.23 |
Sale (Purchase) of Intangibles | -0.01 | -0 | -0.01 | -0 | -0.01 |
Other Investing Activities | -0.03 | -0.11 | -0.01 | 0.23 | -0.01 |
Investing Cash Flow | -0.58 | -0.96 | -0.35 | 0.14 | -0.24 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 42.93 | - | 0.15 | - | - |
Long-Term Debt Repaid | -4.74 | -4.16 | -3.77 | -4.74 | -3.74 |
Net Debt Issued (Repaid) | 38.19 | -4.16 | -3.62 | -4.74 | -3.74 |
Issuance of Common Stock | 1.54 | - | 60.15 | - | - |
Other Financing Activities | -2.31 | -0.98 | -9.77 | -0.92 | -1.44 |
Financing Cash Flow | 37.42 | -5.14 | 46.77 | -5.65 | -5.18 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.4 | 0.09 | -0.05 | 0.08 | 0.06 |
Net Cash Flow | 3.01 | -25.55 | 33.9 | -42.53 | -35.23 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -33.96 | -20.4 | -12.8 | -37.2 | -30.1 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -104.19% | - | -35.36% | -778.79% | -1137.14% |
Free Cash Flow Per Share | -0.71 | -0.43 | -0.35 | -1.07 | -0.87 |
Levered Free Cash Flow | -7.89 | -33.16 | -5.35 | -24.74 | -13.94 |
Unlevered Free Cash Flow | -1.4 | -28.1 | -0.36 | -21.09 | -13.52 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.53 | 0.98 | 6.98 | 0.92 | 1.13 |
Cash Income Tax Paid | 0.2 | 0.06 | 0.01 | - | - |
Change in Working Capital | -3.4 | 14.28 | 9.92 | 2.3 | 11.54 |